Sernova Corp T.SVA

Too many people are expecting SVA to take off by late June

[rixpix]

It's never a good sign for a stock when almost everyone expects something significant announced that will make the shares take off.
Hope i'm wrong but that hardly ever happens.
I see a few disappointed shareholders by the end of next month.

No one expected SVA to triple in January but it did, now we expect SVA to take off again within a month?
I don't know about that.

GLTA..

[MoneyMouth]

Well Sernova has said that they leave their FDA trial updates to the clinical investigator. Their clinical investigator is presenting at the American Diabetes Association conference. Positive trial results make the share price go up. No one is arbitrarily expecting the share price to go up in June.

[BioTeck]

Hoping yes, expecting no. You never expect anything in the stock market unless you're a total fool. Regardless, if the price does go up, it will be met with heavy selling unless they release some unexpected news. Phil thinks he is being coy by dropping little hints in presentations and updates but I think it sets expectations. By the time they finally get around to it, there is no excitement

[Metalsguy1]

My thoughts exactly rixpix. The term that comes to mind is irrational exuberance. Given the snails pace of just getting 5 patients implanted and the fact that we still don't have 7 implanted, I find it hard to believe that 6 months has born that much new study data.

[Redbaron2211]

Rixpix I remember you selling at 70c in December before things took off with a very similar thesis.  Most of us anticipated something good in Jan.   I'm not holding my breath for data to bring this to 3$+ however it could with another cycle into growth.    Collaboration is the catalyst we are all waiting for and will provide plenty of opportunity to sell into strength.

[BioTeck]

Don't sell shame red. I'm sure you've sold a good amount as well. As long as you're making more money than the index you're doing alright.

[woundedknee]

Red says"collaboration is the catalyst we are waiting for". Do you think so? Will it send us higher? I own two other health stocks that have had collaboration announcements and both stocks are down. I'm sure a lot will depend on what that announcement consists of. One, VPT, announced with GE and the price has fallen dramatically since then. And the other ATE announced several

[BioTeck]

The way I see it, anything expected is already built into the price. It's the unexpected that moves stocks. Let's hope we get something unexpected. If not, we'll be holding on for a year or 2 longer. That's my opinion anyways. Let's not forget not one but 2 collaborations were announced which did nothing for the price at the time but is likely why we haven't fell below 1.20

[Redbaron2211]

Collaboration with big names & $$$.  The fact that it's a very real possibility is the reason we are trading above 1.20.   Woundedknee the collaborations VTP and ATE have are not what I'm referring to.    

[woundedknee]

So what are you referring to? We have no idea who Antibe is collaborating with as their CEO has just stated "many". I assume they are far from significant or the stock would be much higher. Obviously, Ventripoint's collab with GE is not a catalyst as their SP has droppef from the 60's to low 40's since the announcement. I'm not disputing what you say, but do not these I

[Metalsguy1]

unfortunately, the unexpected can be negative or positive. The fact that Phil sitting on a 30 million dollar bank and there has been ZERO news on any kind of spending that would indicate heightened levels of activity.

[rixpix]

Yes Red. You, and many others here seem to remember that trade very well. Lol. For the record, it was 39,500 shares @ 71 cents, (not .70) That was a lot better than some here that were selling weeks before @ 40 cents because SVA had doubled with a few months. But that was then, and just b/c it took off then doesn't mean it'll do the same now. Stocks hardly ever double and triple in price